GFP
IDXX icon

Gryphon Financial Partners’s Idexx Laboratories IDXX Stock Holding History

Gryphon Financial Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
546
+74
+16% +$41.5K 0.03% 312
2026
Q1 		$265K Buy
472
+145
+44% +$93K 0.03% 305
2025
Q4 		$221K Buy
+327
New +$223K 0.02% 320
2025
Q3 		– Sell
-406
Closed -$218K – 331
2025
Q2 		$218K Buy
+406
New +$194K 0.03% 291
2022
Q2 		– Sell
-291
Closed -$159K – 250
2022
Q1 		$159K Sell
291
-16
-5% -$8.42K 0.03% 192
2021
Q4 		$202K Sell
307
-24
-7% -$15.1K 0.04% 198
2021
Q3 		$206K Buy
+331
New +$222K 0.05% 188

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Gryphon Financial Partners's IDXX Position: Q2 2026 in Review

Gryphon Financial Partners increased its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, buying an estimated $41.5K and bringing the position to 546 shares worth $287K. The position accounts for 0.03% of the portfolio, ranked #312.

Gryphon Financial Partners first reported a position in IDXX in Q3 2021 and has held it in 7 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Gryphon Financial Partners held 546 shares of Idexx Laboratories worth $287K as of Q2 2026.
  • Gryphon Financial Partners bought 74 Idexx Laboratories shares in Q2 2026, an estimated $41.5K.
  • Idexx Laboratories made up 0.03% of Gryphon Financial Partners's portfolio in Q2 2026, its #312 holding.
  • Gryphon Financial Partners first reported a position in Idexx Laboratories in Q3 2021 and has held it in 7 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.